Results 201 to 210 of about 256,170 (263)

PCSK9 in peripheral arterial disease: Mechanisms and therapeutic perspectives. [PDF]

Sci Prog
Gao Y, Zhang J, Jiang N, Wang L, Cao T, Xie Y, He H, Li L.   +7 more
europepmc   +1 more source

Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis. [PDF]

Diabetes Ther
Elliott B, Tomlinson E, Desai N, Heald A, Field BC, Heiss C, Whyte MB.   +6 more
europepmc   +1 more source

Association of monocyte-lymphocyte ratio with peripheral arterial disease in US participants: a retrospective cross-sectional study. [PDF]

Front Cardiovasc Med
Liu Q, Wu X, Shi J.
europepmc   +1 more source

Peripheral arterial disease: Gap in the knowledge and awareness of associated risk factors in the general population of Saudi Arabia. [PDF]

J Family Med Prim Care
Alkhatieb MT, Aljilani LA, Alkhalifah HA, Alsulymani BM, Alhudaifi SA, Alnahdi HM, Abdullah AM.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Peripheral Arterial Disease

Circulation, 2006
Tram Dang
exaly   +3 more sources